Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ribonucleotide-Diphosphate Reductase Subunit M2 (Rrm2) Expression and Colorectal Cancer Invasiveness: A Potential Prognostic Biomarker Publisher Pubmed



Yazdanian Z1 ; Mobarra N2 ; Fazel A3 ; Fazeli MS4 ; Ghasemi S1, 2 ; Danesteh S5 ; Khoshrou A5 ; Pakzad R6 ; Raji S7 ; Rafiee M5 ; Akbar S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biochemistry, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  2. 2. Department of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Department of Surgery, Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran
  4. 4. Department of General Surgery, School of Medicine Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6. Department of Epidemiology, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran
  7. 7. Persian Cohort Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Molecular Biology Reports Published:2025


Abstract

Background: By evaluating serum Ribonucleotide-diphosphate Reductase subunit M2 (RRM2) levels and mRNA tissue expression, we aimed to investigate the potential role of RRM2 as a prognostic biomarker in Colorectal Cancer (CRC) patients. Methods: This descriptive-analytic cohort study was conducted on 50 newly diagnosed CRC patients (stage II, III). Real-time PCR determined the mRNA tissue expression of RRM2. Fifty healthy individuals who came to the hospital of Golestan University of Medical Sciences and Tehran University of Medical Sciences for routine check-ups were considered the control group. Serum RRM2 protein was measured using an ELISA method in the patient group before, one month, and three months after the surgery, and in the control group just on the day of a routine check-up. The tumor metastasis node (TMN) classification system and occurrence of liver metastasis were evaluated in CRC patients. Results: The RRM2 gene expression ratio and 95% confidence interval (CI) of the cancerous tissue was 6.56 times higher than the normal tissue (p < 0.001). Blood Sugar level (BS) (p < 0.001) and platelet level (PLT [range 0.004–499 × 103 /mm3]; p = 0.010) were higher in the case group compared with the control group significantly, while Mean Corpuscular Volume (MCV) was significantly lower in the case group (p = 0.015). Overall, the mean serum of RRM2 protein levels in patients was remarkably diminished from before surgery until three months after surgery (p < 0.001). Conclusion: Serum RRM2 level and mRNA expression were significantly higher among CRC patients which could be considered a biomarker regarding CRC progression. © The Author(s), under exclusive licence to Springer Nature B.V. 2025.
Related Docs
1. The Multifaceted Role of Extracellular Vesicles (Evs) in Colorectal Cancer: Metastasis, Immune Suppression, Therapy Resistance, and Autophagy Crosstalk, Journal of Translational Medicine (2024)
2. Expression Patterns and Clinical Significance of the Potential Cancer Stem Cell Markers Oct4 and Nanog in Colorectal Cancer Patients, Molecular and Cellular Oncology (2020)
3. Diagnostic Value of Peripheral Blood Inflammatory Indices for Clinicopathological Profile of Colorectal Cancer: A Retrospective Observational Study, BMC Gastroenterology (2025)
Experts (# of related papers)
Nima Rezaei (1)
Hanieh Radkhah (1)